Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
XLock BioSciences Logo
XLock BioSciences Growth Score
72
CB Rank
170339
Heat Score
40
XLock BioSciences develops novel engineered chemokine proteins.
Founded
obfuscation
PrivateGrant Milwaukee, Wisconsin, United States1-10 www.xlockbio.com
Biotechnology
Overview

XLock BioSciences
Total Funding
obfuscation
Growth Score
72
Heat Score
40

Total Funding
obfuscation
obfuscation
Grant raised
obfuscation
Growth Score72
0 pts
in past quarter
Heat Score 40
7 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About XLock BioSciences

CB Rank
170339
XLock BioSciences develops novel engineered chemokine proteins.
Founded
obfuscation
PrivateGrant Milwaukee, Wisconsin, United States1-10 www.xlockbio.com
Biotechnology

Funding Rounds

Grant
OBF
in
obfuscation

Key People

Details

Legal Name XLOCK BIOSCIENCES, LLC
Operating Status Active
Company Type For Profit
Founders  Brian Volkman, Chad Koplinski, Francis Peterson, Michael Dwinell
About the Company
XLock BioSciences develops novel engineered chemokine proteins that have therapeutic utility through well-understood biological mechanisms.
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

XL106
A chemokine-targeted therapy in development for treating immune-related diseases and cancers by modulating chemokine pathways with precision.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - XLock BioSciences Logo
Grant - XLock BioSciences
1
obfuscation
SBIR AdvanceGrant
obfuscation
Grant - XLock BioSciences Logo
Grant - XLock BioSciences
1
obfuscation
SBIR AdvanceGrant
obfuscation
Grant - XLock BioSciences Logo
Grant - XLock BioSciences
1
obfuscation
SBIR AdvanceGrant
obfuscation
Grant - XLock BioSciences Logo
Grant - XLock BioSciences
1
obfuscation
SBIR AdvanceGrant
obfuscation
Grant - XLock BioSciences Logo
Grant - XLock BioSciences
1
obfuscation
SBIR AdvanceGrant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - XLock BioSciences Logo
Grant - XLock BioSciences
1
obfuscation
SBIR AdvanceGrant
obfuscation
Grant - XLock BioSciences Logo
Grant - XLock BioSciences
1
obfuscation
SBIR AdvanceGrant
obfuscation
Grant - XLock BioSciences Logo
Grant - XLock BioSciences
1
obfuscation
SBIR AdvanceGrant
obfuscation
Grant - XLock BioSciences Logo
Grant - XLock BioSciences
1
obfuscation
SBIR AdvanceGrant
obfuscation
Grant - XLock BioSciences Logo
Grant - XLock BioSciences
1
obfuscation
SBIR AdvanceGrant

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 6 Contacts 3

Employee Profiles

News
Technology
View Tech Report

IT Spend

$193.4KThis year, XLock BioSciences is projected to spend $193.4K on IT, according to Aberdeen.

Active Website Tech Count

3XLock BioSciences is actively using 3 technologies for its website, according to BuiltWith. These include Common Crawl, CommonCrawl Top 50m, and  Cloudflare Bot Manager.
Sub-Organizations
Frequently Asked Questions

Where is XLock BioSciences's headquarters? XLock BioSciences is located in Milwaukee, Wisconsin, United States.Who invested in XLock BioSciences? XLock BioSciences is funded by SBIR Advance.When was the last funding round for XLock BioSciences? XLock BioSciences closed its last funding round on
obfuscation
from a Grant round.Who are XLock BioSciences's competitors? Alternatives and possible competitors to XLock BioSciences may include Sanofi, Amgen, and  Aptevo Therapeutics.How much funding has XLock BioSciences raised to date? XLock BioSciences has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(f5c9efb 1)
|